Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins

Virology

Volumn 350, Issue 2, 2006, Pages 312-322

  Tang, Jie ^a   Olive, Melanie ^a   Pulmanausahakul, Rojjanaporn ^a   Schnell, Matthias ^a   Flomenberg, Neal ^a,b   Eisenlohr, Laurence ^a,b   Flomenberg, Phyllis ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adenovirus; CD8 T lymphocytes; CTL; Epitopes; Hexon; HLA A2; Immunotherapy; Stem cell transplantation

Indexed keywords

CAPSID PROTEIN; CYTOKINE; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADENOVIRUS; ARTICLE; CD8+ T LYMPHOCYTE; CELL LINE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DONOR; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEROTYPE; VIRUS INFECTION;

ADENOVIRIDAE; ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC MEMORY; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC;

ADENOVIRIDAE; MIRIDAE;

EID: 33745264376     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.01.024     Document Type: Article

References (38)

1. Albert M.L., Sauter B., and Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392 (1998) 86-89
2. Bordigoni P., Carret A.S., Venard V., Witz F., and Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 32 (2001) 1290-1297
3. Bunde T., Kirchner A., Hoffmeister B., et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201 (2005) 1031-1036
4. Chakrabarti S., Brechling K., and Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5 (1985) 3403-3409
5. Chakrabarti S., Collingham K.E., Fegan C.D., Pillay D., and Milligan D.W. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?. Bone Marrow Transplant. 26 (2000) 305-307
6. Chakrabarti S., Mautner V., Osman H., et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100 (2002) 1619-1627
7. Flomenberg P., Babbitt J., Drobyski W.R., et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J. Infect. Dis. 169 (1994) 775-781
8. Flomenberg P., Piaskowski V., Truitt R.L., and Casper J.T. Characterization of human proliferative T cell responses to adenovirus. J. Infect. Dis. 171 (1995) 1090-1096
9. + T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J. Virol. 70 (1996) 6314-6322
10. Hong J.S., and Engler J.A. The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal. Virology 185 (1991) 758-767
11. Hromas R., Cornetta K., Srour E., Blanke C., and Broun E.R. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 84 (1994) 1689-1690
12. Jooss K., Ertl H.C., and Wilson J.M. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J. Virol. 72 (1998) 2945-2954
13. Kelly Jr. T.J., and Lewis Jr. A.M. Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome. J. Virol. 12 (1973) 643-652
14. Kojaoghlanian T., Flomenberg P., and Horwitz M.S. The impact of adenovirus infection on the immunocompromised host. Rev. Med. Virol. 13 (2003) 155-171
15. + T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles. Hum. Immunol. 64 (2003) 440-452
16. Larsson M., Fonteneau J.F., and Bhardwaj N. Cross-presentation of cell-associated antigens by dendritic cells. Curr. Top. Microbiol. Immunol. 276 (2003) 261-275
17. Leen A.M., Sili U., Savoldo B., et al. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 103 (2004) 1011-1019
18. + T cells. Blood 104 (2004) 2432-2440
19. Legrand F., Berrebi D., Houhou N., et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 27 (2001) 621-626
20. Leon R.P., Hedlund T., Meech S.J., et al. Adenoviral-mediated gene transfer in lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13159-13164
21. Ljungman P., Ribaud P., Eyrich M., et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 31 (2003) 481-486
22. Morsy M.A., Gu M., Motzel S., et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7866-7871
23. + T cell responses from healthy adults. Viral Immunol. 14 (2001) 403-413
24. + T-cell epitope. Hum. Gene Ther. 13 (2002) 1167-1178
25. Papadopoulos E.B., Ladanyi M., Emanuel D., et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330 (1994) 1185-1191
26. Parker K.C., Bednarek M.A., and Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152 (1994) 163-175
27. Rooney C.M., Smith C.A., Ng C.Y., et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92 (1998) 1549-1555
28. Rux J.J., Kuser P.R., and Burnett R.M. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J.Virol. 77 (2003) 9553-9566
29. Sakurai F., Mizuguchi H., Yamaguchi T., and Hayakawa T. Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector. Mol. Ther. 8 (2003) 813-821
30. Schiedner G., Morral N., Parks R.J., et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18 (1998) 180-183
31. Smith G.L., Levin J.Z., Palese P., and Moss B. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 160 (1987) 336-345
32. Smith C.A., Woodruff L.S., Rooney C., and Kitchingman G.R. Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. Hum. Gene Ther. 9 (1998) 1419-1427
33. Tang J., Olive M., Champagne K., et al. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Ther. 11 (2004) 1408-1415
34. + T cells. Clin. Cancer Res. 11 (2005) 5292-5299
35. Walter E.A., Greenberg P.D., Gilbert M.J., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333 (1995) 1038-1044
36. Wysocka M., Eisenlohr L.C., Otvos Jr. L., et al. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation. Virology 201 (1994) 86-94
37. Yang S.Y., Milford E., Hammerling U., and Dupont B. Description of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system: the B-cell line panel designed for the Tenth International Histocompatibility Workshop. In: Dupont B. (Ed). Immunobiology of HLA. Histocompatibility Testing vol. I (1987), Springer-Verlag, New York 11-19
38. Yang Y., Nunes F.A., Berencsi K., Furth E.E., Gonczol E., and Wilson J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4407-4411